University of Washington, Fred Hutchinson Cancer Research Center
University of Washington, Fred Hutchinson Cancer Research Center
Seattle, Washington, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer | HER2 positive breast carcinoma, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, male breast carcinoma, neoplasm, skin disorder | Active, not recruiting | Phase 2 | 2026-03-06 | NCT03384914 |